About the Cost of Opposing the Coumarin-lnhibitor Theory

Thromb Haemost 1983; 49(03): 246
DOI: 10.1055/s-0038-1657373

Letter to the Editor

Schattauer GmbH Stuttgart

Antonio Girolami

Institute of Medical Semeiotics and Second Chair of Medicine, Padua, Italy

References
1 Losito R. Coumarin-induced pre-factors or inhibitors. Thromb Haemostas 1982; 48: 240
2 Losito R. Investigation into the presence of a competitive inhibition (preprothrombin) in the plasma of chicks. Acta Med Scand 1965; 19: 2229-2234
3 Girolami A, Patrassi GM, Fabris F, Dal BoZanon. Additional evidence against the presence of inhibitors in Vit. K deficiency and in coumarin-treated patients. Thromb Haemostas 1981; 45: 192
4 Girolami A, Dal Bo Zanon R, Sticchi A. Apparent inhibition as tested by means of the dilution curve system in patients with clotting defect due to liver damage. Blut 1977; 35: 247-252
5 Diejen-Visser MP, Wersch J, Brombacher PJ, Rosing J, Hemker HC, Diejen G. Use of chromogenic peptide substrates in the determination of clotting factors II VII, IX and X in normal plasma and plasma of patients treated with oral anticoagulants. Haemostasis 1982; 12: 241-255
6 Broad WJ. Harvard delays in reporting fraud. Science 1982; 215: 478-482
7 Editorial Prevention of dishonesty in Science. Science 1982; 215: 876-877
8 Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978; 91: 387-395